| Improved survival with MEK inhibition in BRAF-mutated melanoma KT Flaherty, C Robert, P Hersey, P Nathan, C Garbe, M Milhem, ... New England Journal of Medicine 367 (2), 107-114, 2012 | 2651 | 2012 |
| Antibody targeted drugs as cancer therapeutics D Schrama, RA Reisfeld, JC Becker Nature reviews Drug discovery 5 (2), 147-159, 2006 | 1044 | 2006 |
| Voluntary running suppresses tumor growth through epinephrine-and IL-6-dependent NK cell mobilization and redistribution L Pedersen, M Idorn, GH Olofsson, B Lauenborg, I Nookaew, RH Hansen, ... Cell metabolism 23 (3), 554-562, 2016 | 858 | 2016 |
| Cytotoxic T cells MH Andersen, D Schrama, P Thor Straten, JC Becker Journal of Investigative Dermatology 126 (1), 32-41, 2006 | 836 | 2006 |
| Germline mutations in BAP1 predispose to melanocytic tumors T Wiesner, AC Obenauf, R Murali, I Fried, KG Griewank, P Ulz, ... Nature genetics 43 (10), 1018-1021, 2011 | 794 | 2011 |
| Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma SJ Whittaker, MF Demierre, EJ Kim, AH Rook, A Lerner, M Duvic, ... Journal of clinical oncology 28 (29), 4485-4491, 2010 | 772 | 2010 |
| Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III … D Schadendorf, S Ugurel, B Schuler-Thurner, FO Nestle, A Enk, ... Annals of Oncology 17 (4), 563-570, 2006 | 610 | 2006 |
| Merkel cell carcinoma JC Becker, A Stang, JA DeCaprio, L Cerroni, C Lebbé, M Veness, ... Nature reviews Disease primers 3 (1), 1-17, 2017 | 575 | 2017 |
| Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline A Stratigos, C Garbe, C Lebbe, J Malvehy, V Del Marmol, H Pehamberger, ... European journal of cancer 51 (14), 1989-2007, 2015 | 547 | 2015 |
| A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth AG Niethammer, R Xiang, JC Becker, H Wodrich, U Pertl, G Karsten, ... Nature medicine 8 (12), 1369-1375, 2002 | 507 | 2002 |
| Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens R Houben, M Shuda, R Weinkam, D Schrama, H Feng, Y Chang, ... Journal of virology 84 (14), 7064-7072, 2010 | 495 | 2010 |
| Merkel cell carcinoma: epidemiology, prognosis, therapy and unmet medical needs D Schadendorf, C Lebbé, A Zur Hausen, MF Avril, S Hariharan, ... European journal of cancer 71, 53-69, 2017 | 447 | 2017 |
| Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays YL Tolstov, DV Pastrana, H Feng, JC Becker, FJ Jenkins, S Moschos, ... International journal of cancer 125 (6), 1250-1256, 2009 | 410 | 2009 |
| Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis R Houben, JC Becker, A Kappel, P Terheyden, EB Bröcker, R Goetz, ... Journal of carcinogenesis 3, 6, 2004 | 397 | 2004 |
| Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. JC Becker, R Dummer, AA Hartmann, G Burg, RE Schmidt Journal of immunology (Baltimore, Md.: 1950) 147 (12), 4398-4401, 1991 | 369 | 1991 |
| Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients MH Andersen, LØ Pedersen, JC Becker, P Straten Cancer research 61 (3), 869-872, 2001 | 364 | 2001 |
| Spontaneous Cytotoxic T-Cell Responses against Survivin-derived MHC Class I-restricted T-Cell Epitopes in Situ As Well As ex Vivo in Cancer Patients MH Andersen, LØ Pedersen, B Capeller, EB Bröcker, JC Becker, ... Cancer research 61 (16), 5964-5968, 2001 | 358 | 2001 |
| Superior skin cancer classification by the combination of human and artificial intelligence A Hekler, JS Utikal, AH Enk, A Hauschild, M Weichenthal, RC Maron, ... European Journal of Cancer 120, 114-121, 2019 | 353 | 2019 |
| Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms DB Johnson, AM Menzies, L Zimmer, Z Eroglu, F Ye, S Zhao, H Rizos, ... European journal of cancer 51 (18), 2792-2799, 2015 | 352 | 2015 |
| Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival KG Paulson, JG Iyer, AR Tegeder, R Thibodeau, J Schelter, S Koba, ... Journal of Clinical Oncology 29 (12), 1539-1546, 2011 | 344 | 2011 |
David SchramaUniversity Hospital Wuerzburg, DermatologyBestätigte E-Mail-Adresse bei ukw.de
